Skip to main content
Erschienen in:

07.01.2021 | Clinical Investigation

Tear protein analysis in patients with primary acquired nasolacrimal duct obstruction treated with lacrimal passage intubation

verfasst von: Shigeharu Yaginuma, Kimihito Konno, Chika Shigeyasu, Masakazu Yamada

Erschienen in: Japanese Journal of Ophthalmology | Ausgabe 3/2021

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The pathophysiology of nasolacrimal duct obstruction (NLDO) may involve quantitative as well as qualitative changes in tears. We measured tear protein concentrations in patients with primary acquired NLDO and compared them with the tear proteins in healthy individuals and patients with dry eye disease.

Study Design

Case–control study.

Methods

Twenty-four patients diagnosed with primary acquired NLDO who underwent endoscopic lacrimal passage intubation were included in the study. Tear fluid was collected with Schirmer’s test strips three times: before intubation, after intubation while the nasolacrimal tube was in place, and after extubation. At the same time, 24 age-matched normal controls and 24 patients with dry eye were selected from subjects whose tears were collected during the same study period. We measured the following components of tear fluid: total protein, lactoferrin, albumin, and interleukin 6 (IL-6) levels.

Results

Total proteins and albumin levels in tears of the NLDO group were significantly lower than those of the control group (P < 0.001 and P = 0.014, respectively, Mann–Whitney U test). Total proteins, albumin, and lactoferrin levels were significantly increased after extubation of nasolacrimal tube (P < 0.001, P = 0.004, and P = 0.029, respectively, Wilcoxon matched-pairs signed-rank test). There were no statistically significant differences in total protein, albumin, lactoferrin and IL-6 levels between patients with NLDO after lacrimal passage extubation and controls.

Conclusions

Our study shows distinct differences in protein composition of tear fluid in NLDO eyes and demonstrates that these can be normalized by nasolacrimal tube placement.
Literatur
1.
Zurück zum Zitat Park DI, Lew H, Lee SY. Tear meniscus measurement in nasolacrimal duct obstruction patients with Fourier-domain optical coherence tomography: novel three-point capture method. Acta Ophthalmol. 2012;90:783–7.CrossRef Park DI, Lew H, Lee SY. Tear meniscus measurement in nasolacrimal duct obstruction patients with Fourier-domain optical coherence tomography: novel three-point capture method. Acta Ophthalmol. 2012;90:783–7.CrossRef
2.
Zurück zum Zitat Ohtomo K, Ueta T, Fukuda R, Usui T, Miyai T, Shirakawa R, et al. Tear meniscus volume changes in dacryocystorhinostomy evaluated with quantitative measurement using anterior segment optical coherence tomography. Invest Ophthalmol Vis Sci. 2014;55:2057–61.CrossRef Ohtomo K, Ueta T, Fukuda R, Usui T, Miyai T, Shirakawa R, et al. Tear meniscus volume changes in dacryocystorhinostomy evaluated with quantitative measurement using anterior segment optical coherence tomography. Invest Ophthalmol Vis Sci. 2014;55:2057–61.CrossRef
3.
Zurück zum Zitat Koh S, Inoue Y, Ochi S, Takai Y, Maeda N, Nishida K. Quality of vision in eyes with epiphora undergoing lacrimal passage intubation. Am J Ophthalmol. 2017;181:71–8.CrossRef Koh S, Inoue Y, Ochi S, Takai Y, Maeda N, Nishida K. Quality of vision in eyes with epiphora undergoing lacrimal passage intubation. Am J Ophthalmol. 2017;181:71–8.CrossRef
4.
Zurück zum Zitat Acera A, Suárez T, Rodríguez-Agirretxe I, Vecino E, Durán JA. Changes in tear protein profile in patients with conjunctivochalasis. Cornea. 2011;30:42–9.CrossRef Acera A, Suárez T, Rodríguez-Agirretxe I, Vecino E, Durán JA. Changes in tear protein profile in patients with conjunctivochalasis. Cornea. 2011;30:42–9.CrossRef
5.
Zurück zum Zitat Pflugfelder SC, Solomon A, Dursun D, Li DQ. Dry eye and delayed tear clearance: “a call to arms.” Adv Exp Med Biol. 2002;506(Pt B):739–43.CrossRef Pflugfelder SC, Solomon A, Dursun D, Li DQ. Dry eye and delayed tear clearance: “a call to arms.” Adv Exp Med Biol. 2002;506(Pt B):739–43.CrossRef
6.
Zurück zum Zitat Lew H, Lee SY, Yun YS. Measurement of pH, electrolytes and electrophoretic studies of tear proteins in tears of patients with dacryoliths: a novel concept for dacryoliths. Ophthalmologica. 2004;218:130–5.CrossRef Lew H, Lee SY, Yun YS. Measurement of pH, electrolytes and electrophoretic studies of tear proteins in tears of patients with dacryoliths: a novel concept for dacryoliths. Ophthalmologica. 2004;218:130–5.CrossRef
7.
Zurück zum Zitat Lee JK, Kim TH. Changes in cytokines in tears after endoscopic endonasal dacryocystorhinostomy for primary acquired nasolacrimal duct obstruction. Eye (Lond). 2014;28:600–7.CrossRef Lee JK, Kim TH. Changes in cytokines in tears after endoscopic endonasal dacryocystorhinostomy for primary acquired nasolacrimal duct obstruction. Eye (Lond). 2014;28:600–7.CrossRef
8.
Zurück zum Zitat Matsumura N, Goto S, Uchio E, Nakajima K, Fujita T, Kadonosono K. Cytokine profiles of tear fluid from patients with pediatric lacrimal duct obstruction. Invest Ophthalmol Vis Sci. 2017;58:252–6.CrossRef Matsumura N, Goto S, Uchio E, Nakajima K, Fujita T, Kadonosono K. Cytokine profiles of tear fluid from patients with pediatric lacrimal duct obstruction. Invest Ophthalmol Vis Sci. 2017;58:252–6.CrossRef
9.
Zurück zum Zitat Fullard RJ, Snyder C. Protein levels in nonstimulated and stimulated tears of normal human subjects. Invest Ophthalmol Vis Sci. 1990;31:1119–26.PubMed Fullard RJ, Snyder C. Protein levels in nonstimulated and stimulated tears of normal human subjects. Invest Ophthalmol Vis Sci. 1990;31:1119–26.PubMed
10.
Zurück zum Zitat Fullard RJ, Tucker DL. Changes in human tear protein levels with progressively increasing stimulus. Invest Ophthalmol Vis Sci. 1991;32:2290–301.PubMed Fullard RJ, Tucker DL. Changes in human tear protein levels with progressively increasing stimulus. Invest Ophthalmol Vis Sci. 1991;32:2290–301.PubMed
11.
Zurück zum Zitat Danjo Y, Lee M, Horimoto K, Hamano T. Ocular surface damage and tear lactoferrin in dry eye syndrome. Acta Ophthalmol. 1994;72:433–7.CrossRef Danjo Y, Lee M, Horimoto K, Hamano T. Ocular surface damage and tear lactoferrin in dry eye syndrome. Acta Ophthalmol. 1994;72:433–7.CrossRef
12.
Zurück zum Zitat Bjerrum KB. The ratio of albumin to lactoferrin in tear fluid as a diagnostic tool in primary Sjögren’s syndrome. Acta Ophthalmol. 1997;75:507–11.CrossRef Bjerrum KB. The ratio of albumin to lactoferrin in tear fluid as a diagnostic tool in primary Sjögren’s syndrome. Acta Ophthalmol. 1997;75:507–11.CrossRef
13.
Zurück zum Zitat Runstrom G, Mann A, Tighe B. The fall and rise of tear albumin levels: a multifactorial phenomenon. Ocul Surf. 2013;11:165–80.CrossRef Runstrom G, Mann A, Tighe B. The fall and rise of tear albumin levels: a multifactorial phenomenon. Ocul Surf. 2013;11:165–80.CrossRef
14.
Zurück zum Zitat Versura P, Bavelloni A, Blalock W, Fresina M, Campos EC. A rapid standardized quantitative microfluidic system approach for evaluating human tear proteins. Mol Vis. 2012;18:2526–37.PubMedPubMedCentral Versura P, Bavelloni A, Blalock W, Fresina M, Campos EC. A rapid standardized quantitative microfluidic system approach for evaluating human tear proteins. Mol Vis. 2012;18:2526–37.PubMedPubMedCentral
15.
Zurück zum Zitat Versura P, Bavelloni A, Grillini M, Fresina M, Campos EC. Diagnostic performance of a tear protein panel in early dry eye. Mol Vis. 2013;19:1247–57.PubMedPubMedCentral Versura P, Bavelloni A, Grillini M, Fresina M, Campos EC. Diagnostic performance of a tear protein panel in early dry eye. Mol Vis. 2013;19:1247–57.PubMedPubMedCentral
16.
Zurück zum Zitat Versura P, Nanni P, Bavelloni A, Blalock WL, Piazzi M, Roda A, et al. Tear proteomics in evaporative dry eye disease. Eye (Lond). 2010;24:1396–402.CrossRef Versura P, Nanni P, Bavelloni A, Blalock WL, Piazzi M, Roda A, et al. Tear proteomics in evaporative dry eye disease. Eye (Lond). 2010;24:1396–402.CrossRef
17.
Zurück zum Zitat Perumal N, Funke S, Pfeiffer N, Grus FH. Proteomics analysis of human tears from aqueous-deficient and evaporative dry eye patients. Sci Rep. 2011;6:29629.CrossRef Perumal N, Funke S, Pfeiffer N, Grus FH. Proteomics analysis of human tears from aqueous-deficient and evaporative dry eye patients. Sci Rep. 2011;6:29629.CrossRef
18.
Zurück zum Zitat Gaffney EA, Tiffany JM, Yokoi N, Bron AJ. A mass and solute balance model for tear volume and osmolarity in the normal and the dry eye. Prog Retin Eye Res. 2010;29:59–78.CrossRef Gaffney EA, Tiffany JM, Yokoi N, Bron AJ. A mass and solute balance model for tear volume and osmolarity in the normal and the dry eye. Prog Retin Eye Res. 2010;29:59–78.CrossRef
19.
Zurück zum Zitat Dartt DA. Regulation of mucin and fluid secretion by conjunctival epithelial cells. Prog Retin Eye Res. 2002;21:555–76.CrossRef Dartt DA. Regulation of mucin and fluid secretion by conjunctival epithelial cells. Prog Retin Eye Res. 2002;21:555–76.CrossRef
20.
Zurück zum Zitat Willcox MDP, Argüeso P, Georgiev GA, Holopainen JM, Laurie GW, Millar TJ, et al. TFOS DEWS II tear film report. Ocul Surf. 2017;15:366–403.CrossRef Willcox MDP, Argüeso P, Georgiev GA, Holopainen JM, Laurie GW, Millar TJ, et al. TFOS DEWS II tear film report. Ocul Surf. 2017;15:366–403.CrossRef
21.
Zurück zum Zitat Shimazaki J, Tsubota K, Kinoshita S, Ohashi Y, Shimomura Y, Tagawa Y, et al. Definition and diagnosis of dry eye. Atarashii Ganka. 2007;4:181–4 ((in Japanese)). Shimazaki J, Tsubota K, Kinoshita S, Ohashi Y, Shimomura Y, Tagawa Y, et al. Definition and diagnosis of dry eye. Atarashii Ganka. 2007;4:181–4 ((in Japanese)).
22.
Zurück zum Zitat van Bijsterveld OP. Diagnostic tests in the Sicca syndrome. Arch Ophthalmol. 1969;82:10–4.CrossRef van Bijsterveld OP. Diagnostic tests in the Sicca syndrome. Arch Ophthalmol. 1969;82:10–4.CrossRef
23.
Zurück zum Zitat Yaginuma S, Akune Y, Shigeyasu C, Takano Y, Yamada M. Tear protein analysis in presumed congenital alacrima. Clin Ophthalmol. 2018;12:2591–5.CrossRef Yaginuma S, Akune Y, Shigeyasu C, Takano Y, Yamada M. Tear protein analysis in presumed congenital alacrima. Clin Ophthalmol. 2018;12:2591–5.CrossRef
24.
Zurück zum Zitat Zhu H, Chauhan A. Tear dynamics model. Curr Eye Res. 2007;32:177–97.CrossRef Zhu H, Chauhan A. Tear dynamics model. Curr Eye Res. 2007;32:177–97.CrossRef
25.
Zurück zum Zitat Cerretani CF, Radke CJ. Tear dynamics in healthy and dry eyes. Curr Eye Res. 2014;39:580–95.CrossRef Cerretani CF, Radke CJ. Tear dynamics in healthy and dry eyes. Curr Eye Res. 2014;39:580–95.CrossRef
26.
Zurück zum Zitat Pearce EI, Tomlinson A, Craig JP, Lowther GE. Tear protein levels following punctal plugging. Adv Exp Med Biol. 1998;438:669–74.CrossRef Pearce EI, Tomlinson A, Craig JP, Lowther GE. Tear protein levels following punctal plugging. Adv Exp Med Biol. 1998;438:669–74.CrossRef
27.
Zurück zum Zitat Sambursky R, Davitt WF, Latkany R, Tauber S, Starr C, Friedberg M, et al. Sensitivity and specificity of a point-of-care matrix metalloproteinase 9 immunoassay for diagnosing inflammation related to dry eye. JAMA Ophthalmol. 2013;131:24–8.CrossRef Sambursky R, Davitt WF, Latkany R, Tauber S, Starr C, Friedberg M, et al. Sensitivity and specificity of a point-of-care matrix metalloproteinase 9 immunoassay for diagnosing inflammation related to dry eye. JAMA Ophthalmol. 2013;131:24–8.CrossRef
28.
Zurück zum Zitat Fischbarg J. Water channels and their roles in some ocular tissues. Mol Aspects Med. 2012;33:638–41.CrossRef Fischbarg J. Water channels and their roles in some ocular tissues. Mol Aspects Med. 2012;33:638–41.CrossRef
29.
Zurück zum Zitat Levin MH, Verkman AS. Aquaporin-dependent water permeation at the mouse ocular surface: in vivo microfluorimetric measurements in cornea and conjunctiva. Invest Ophthalmol Vis Sci. 2004;45:4423–32.CrossRef Levin MH, Verkman AS. Aquaporin-dependent water permeation at the mouse ocular surface: in vivo microfluorimetric measurements in cornea and conjunctiva. Invest Ophthalmol Vis Sci. 2004;45:4423–32.CrossRef
30.
Zurück zum Zitat Levin MH, Kim JK, Hu J, Verkman AS. Potential difference measurements of ocular surface Na+ absorption analyzed using an electrokinetic model. Invest Ophthalmol Vis Sci. 2006;47:306–16.CrossRef Levin MH, Kim JK, Hu J, Verkman AS. Potential difference measurements of ocular surface Na+ absorption analyzed using an electrokinetic model. Invest Ophthalmol Vis Sci. 2006;47:306–16.CrossRef
31.
Zurück zum Zitat Zhou L, Zhao SZ, Koh SK, Chen L, Vaz C, Tanavde V, et al. In-depth analysis of the human tear proteome. J Proteomics. 2012;75:3877–85.CrossRef Zhou L, Zhao SZ, Koh SK, Chen L, Vaz C, Tanavde V, et al. In-depth analysis of the human tear proteome. J Proteomics. 2012;75:3877–85.CrossRef
32.
Zurück zum Zitat Azkargorta M, Soria J, Acera A, Iloro I, Elortza F. Human tear proteomics and peptidomics in ophthalmology: toward the translation of proteomic biomarkers into clinical practice. J Proteomics. 2017;150:359–67.CrossRef Azkargorta M, Soria J, Acera A, Iloro I, Elortza F. Human tear proteomics and peptidomics in ophthalmology: toward the translation of proteomic biomarkers into clinical practice. J Proteomics. 2017;150:359–67.CrossRef
33.
Zurück zum Zitat Boehm N, Funke S, Wiegand M, Wehrwein N, Pfeiffer N, Grus FH. Alterations in the tear proteome of dry eye patients-a matter of the clinical phenotype. Invest Ophthalmol Vis Sci. 2013;54:2385–92.CrossRef Boehm N, Funke S, Wiegand M, Wehrwein N, Pfeiffer N, Grus FH. Alterations in the tear proteome of dry eye patients-a matter of the clinical phenotype. Invest Ophthalmol Vis Sci. 2013;54:2385–92.CrossRef
34.
Zurück zum Zitat Wei Y, Gadaria-Rathod N, Epstein S, Asbell P. Tear cytokine profile as a noninvasive biomarker of inflammation for ocular surface diseases: standard operating procedures. Invest Ophthalmol Vis Sci. 2013;54:8327–36.CrossRef Wei Y, Gadaria-Rathod N, Epstein S, Asbell P. Tear cytokine profile as a noninvasive biomarker of inflammation for ocular surface diseases: standard operating procedures. Invest Ophthalmol Vis Sci. 2013;54:8327–36.CrossRef
35.
Zurück zum Zitat Enríquez-de-Salamanca A, Castellanos E, Stern ME, Fernández I, Carreño E, García-Vázquez C, et al. Tear cytokine and chemokine analysis and clinical correlations in evaporative-type dry eye disease. Mol Vis. 2010;16:862–73.PubMedPubMedCentral Enríquez-de-Salamanca A, Castellanos E, Stern ME, Fernández I, Carreño E, García-Vázquez C, et al. Tear cytokine and chemokine analysis and clinical correlations in evaporative-type dry eye disease. Mol Vis. 2010;16:862–73.PubMedPubMedCentral
Metadaten
Titel
Tear protein analysis in patients with primary acquired nasolacrimal duct obstruction treated with lacrimal passage intubation
verfasst von
Shigeharu Yaginuma
Kimihito Konno
Chika Shigeyasu
Masakazu Yamada
Publikationsdatum
07.01.2021
Verlag
Springer Japan
Erschienen in
Japanese Journal of Ophthalmology / Ausgabe 3/2021
Print ISSN: 0021-5155
Elektronische ISSN: 1613-2246
DOI
https://doi.org/10.1007/s10384-020-00804-6

Neu im Fachgebiet Augenheilkunde

Kompetente Gesprächsführung

Mit schwierigen Gesprächen und der Übermittlung schlechter Nachrichten ist der Augenarzt/die Augenärztin im Krankenhaus und in der Praxis immer wieder konfrontiert. Eine gute Arzt-Patienten-Kommunikation basiert auf Respekt und Empathie und …

Sekundäre chorioidale Neovaskularisation – Wirklich so häufig?

Das Auftreten einer sekundären chorioidalen Neovaskularisation ist eine Komplikation im Rahmen einer chronischen Chorioretinopathia centralis serosa. Die Diagnose wird mittels multimodaler Bildgebung gestellt. Die Therapie erfolgt in der Regel mit …

Therapie der Chorioretinopathia centralis serosa im Vergleich – Mikrosekundenpulslaser versus photodynamische Therapie

Zum gegenwärtigen Zeitpunkt steht für die Behandlung der Chorioretinopathia centralis serosa (CCS) keine zugelassene Therapie zur Verfügung. Obwohl die CCS eine hohe Selbstresorptionsrate aufweist, können häufige Rezidive oder eine Chronifizierung …

Diagnostik und Klassifikation der Chorioretinopathia centralis serosa – Was brauche ich wirklich?

Die multimodale Bildgebung spielt bei der Diagnostik und Klassifikation der Chorioretinopathia centralis serosa (CCS) eine bedeutende Rolle. In diesem Beitrag sollen die wichtigsten Bildgebungsmodalitäten bei der CCS wie optische …

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.